1. Rubio-Tapia A, Herman ML, Ludvigsson JF, et al. Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc. 2012; 87:732–738.
2. Ianiro G, Bibbò S, Montalto M, Ricci R, Gasbarrini A, Cammarota G. Systematic review: sprue-like enteropathy associated with olmesartan. Aliment Pharmacol Ther. 2014; 40:16–23.
3. Kamal A, Fain C, Park A, et al. Angiotensin II receptor blockers and gastrointestinal adverse events of resembling spruelike enteropathy: a systematic review. Gastroenterol Rep (Oxf). 2019; 7:162–167.
4. Herman ML, Rubio-Tapia A, Wu TT, Murray JA. A case of severe sprue-like enteropathy associated with valsartan. ACG Case Rep J. 2015; 2:92–94.
5. Soldera J, Salgado K. Gastrointerestinal: valsartan induced sprue-like enteropathy. J Gastroenterol Hepatol. 2020; 35:1262.